Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Management of Viral Upper Respiratory Tract Infections

Diagnosis and Treatment Approach

  • The American Academy of Otolaryngology-Head and Neck Surgery suggests that viral URTIs typically present with symptoms such as cough, sneezing, rhinorrhea, sore throat, and nasal congestion 3
  • Discolored nasal discharge alone does not indicate bacterial infection; it is a sign of inflammation and not specific for infection, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • The American Academy of Otolaryngology-Head and Neck Surgery recommends analgesics/antipyretics, such as acetaminophen or ibuprofen, for pain, fever, and inflammation 2
  • Oral decongestants may provide symptomatic relief if no contraindications, according to the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Topical decongestants can be used but should not exceed 3-5 days to avoid rebound congestion, as advised by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Nasal saline irrigation may provide minor improvements in nasal symptoms, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Dextromethorphan or codeine can be prescribed for dry, bothersome cough, according to the European Respiratory Journal 4
  • Expectorants, such as guaifenesin, may be used for symptomatic relief, though evidence of clinical efficacy is limited, as stated by the American Academy of Otolaryngology-Head and Neck Surgery and Chest 2, 3
  • Adequate hydration and rest are recommended as supportive measures, as advised by Nature Reviews Disease Primers 5

Antibiotic Use and Prevention

  • The American Academy of Otolaryngology-Head and Neck Surgery and the European Respiratory Journal state that antibiotics are not recommended for viral URTIs as they are ineffective for viral illness and do not provide direct symptom relief 2, 4
  • Unnecessary antibiotic use contributes to antibiotic resistance, as warned by Clinical Microbiology and Infection 1
  • Influenza vaccination can reduce influenza-associated URTIs, according to Nature Reviews Disease Primers 7, 5
  • Hand hygiene and avoiding close contact with infected individuals can help prevent URTIs, as recommended by Rhinology 6
  • Nasal washing with saline solution may have prophylactic benefits, as suggested by Rhinology 6

Special Considerations and Follow-up

  • Topical intranasal steroids may have a role in managing viral rhinosinusitis, though not FDA-approved for this purpose, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Antiviral treatments should be considered only in high-risk patients with typical influenza symptoms present for <2 days during a known influenza epidemic, according to the European Respiratory Journal 4
  • Patients should be advised to return if symptoms persist beyond 3 weeks, fever exceeds 4 days, dyspnea worsens, or patient stops drinking or consciousness decreases, as recommended by the European Respiratory Journal 4
  • Antibiotics should be considered only in specific circumstances, such as suspected or definite pneumonia, age >75 years with fever, cardiac failure, insulin-dependent diabetes mellitus, or serious neurological disorder, as stated by the European Respiratory Journal 4